エピソード

  • Getting Technology Into the Clinic
    2024/10/18

    Getting genuinely useful new technologies, from wearables to clinical decision support, into the clinic has proven to be surprisingly challenging. Tanzeem K. Choudhury, PhD, of Cornell Tech joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss how to take research into the real world in a way that is scalable and affordable.

    Related Content:

    • How Health and Technology Sectors Can Collaborate on Better AI-Assisted Wearables
    続きを読む 一部表示
    26 分
  • What Lessons Does the VA’s Experience Building Electronic Health Records Hold for AI?
    2024/10/08

    What hard lessons did the US Department of Veterans Affairs (VA) learn in 3 decades of EHR development, and what can it teach us about building better AI in medicine? Stephen Fihn, MD, MPH, of the University of Washington, and formerly a leader in the VA’s EHR efforts, joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss his experience at the VA building decision support tools and other technology.

    Related Content:

    • The VA Was an Early Adopter of Artificial Intelligence to Improve Care—Here’s What They Learned
    • Hello, World—Introducing JAMA+ AI
    続きを読む 一部表示
    23 分
  • Heart Health Highlights From ESC Congress
    2024/10/04

    European Society of Cardiology Vice President Carlos Aguiar, MD, discusses clinical research highlights from the largest scientific meeting in cardiovascular medicine, held recently in London. Updates include semaglutide findings, hypertension triple pills, and more.

    Related Content:

    • Semaglutide Updates, Hypertension Triple Pills, and More—Heart Health Highlights From ESC Congress
    続きを読む 一部表示
    19 分
  • September 2024 Medical News Summary
    2024/09/27

    Related Content:

    • The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits
    • New Guidance Helps Clinicians Use Pemivibart to Protect Immunocompromised Patients From COVID-19
    続きを読む 一部表示
    16 分
  • Lasker Winners Discuss 35 Years of HIV Research in Africa
    2024/09/19

    Quarraisha Abdool Karim, PhD, and Salim S. Abdool Karim, MBChB, PhD, are the recipients of the 2024 Lasker-Bloomberg Public Service Award for their decades of work on AIDS in Africa. The infectious diseases epidemiologists recently reflected on their life’s work in a conversation with JAMA Deputy Editor and infectious diseases physician Preeti Malani, MD, MSJ.

    Related Content:

    • Thirty-Five Years of HIV Research in Africa—An Interview With Winners of the 2024 Lasker-Bloomberg Public Service Award
    • AIDS in Africa—Impact of Research
    続きを読む 一部表示
    24 分
  • Three Years Later, Here’s What the Pacific Northwest Heat Dome Taught Us
    2024/09/06

    Extreme heat and its health outcomes are becoming more common. Jeremy Hess, MD, MPH, an emergency medicine physician and professor at the University of Washington, and Andrew Phelps, former director of the Oregon Department of Emergency Management, join Jennifer Abbasi, director of JAMA Medical News, to discuss lessons learned from the unprecedented heat wave in June 2021.

    Related Content:

    • As Extreme Heat Becomes More Common, the Unprecedented Pacific Northwest Heat Dome Offers Lessons
    続きを読む 一部表示
    27 分
  • August 2024 Medical News Summary
    2024/08/30

    Here’s What to Know About the New Mpox Global Emergency; Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes

    Related Content:

    • As Mpox Cases Surge in Africa, WHO Declares a Global Emergency—Here’s What to Know
    • Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth
    続きを読む 一部表示
    13 分
  • Highlights From the Alzheimer’s Association International Conference
    2024/08/16

    Sebastian Palmqvist, MD, PhD, and Wiesje van der Flier, PhD, cochairs of the 2024 Alzheimer’s Association International Conference, speak with JAMA Medical News Lead Senior Staff Writer Rita Rubin, MA, about highlights from the annual meeting, including a blood test for Alzheimer disease, repurposing of a GLP-1 receptor agonist, and the possible brain risk from inhaling wildfire smoke.

    Related Content:

    • A Blood Test for Alzheimer Disease, Repurposing GLP-1s, and Wildfire Smoke—Highlights From the AAIC
    続きを読む 一部表示
    22 分